Elosalic

Medicinal product

(Invented) name

Elosalic

Active substance (s)

Mometazono furoatas/Salicilo rūgštis

Strength

1 mg/50 mg/g

Pharmaceutical form

tepalas

Route (s) of administration

vartoti ant odos

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D07XC03, Mometasone

Marketing authorisation holder

Merck Sharp & Dohme B.V., Nyderlandai

Date of authorisation

2006-10-09

Date of renewal

2008-04-17

Documents

0456_1_4 Elosalic tepalas RPP 181005.docx

0456_1_4 Pakuotės lapelis 181005.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

SE/H/0217/001/E/002

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

1 g tepalo yra	1 g
Mometazono furoatas	1 mg
Salicilo rūgštis	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
17118	21069	1021069	tūbelė	15 g, N1		Receptinis	LT/1/06/0456/001	Netiekiama	-	-	No	-	-
17119	21070	1021070	tūbelė	25 g, N1		Receptinis	LT/1/06/0456/002	Netiekiama	-	-	No	-	-
17120	4834	1004834	tūbelė	45 g, N1		Receptinis	LT/1/06/0456/003	Netiekiama	-	-	No	-	-	Download
17121	21071	1021071	tūbelė	50 g, N1		Receptinis	LT/1/06/0456/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-10-02	Išregistruotas
2008-04-17	Perregistruotas
2006-10-09	Registruotas